The SphK1/S1P pathway is known to play an essential role in the development of PAH by activation of NF-κB which then up-regulates the expression of cyclin D1; this leads to PASMCs proliferation and pulmonary vascular remodeling. The gene discussed is NFKB1; the disease is pulmonary arterial hypertension.